JPRN-UMIN000015369
Completed
未知
The study of dapagliflozin (sodium glucose cotransporter 2 inhibitor) to verify the efficacy of combination therapy in Japanese patients with type 2 diabetes - DISCOVERY study
Okayama University Hospital nephrology, diabates and endocrinology0 sites100 target enrollmentOctober 8, 2014
ConditionsType 2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes
- Sponsor
- Okayama University Hospital nephrology, diabates and endocrinology
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) type 1 diabetes 2\) BMI: \>\= 45 3\) patients suspected of pregnancy or pregnant or nursing 4\) diabetes insipidus 5\) severe liver dysfunction (liver cirrhosis, viral hepatitis, AST: \>\= 3 times of upper limit) 6\) moderate renal dysfunction (eGFR: \< 45 ml/min/1\.73m2\) 7\) heart disease (myocardial infarction, unstable angina) or stroke within 3 months 8\) considered as inadequate by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
sage of Dapagliflozin in the management of Type-2 Diabetes Mellitus in Indian patientsHealth Condition 1: null- Type 2 DiabetesCTRI/2017/03/008011AstraZeneca Pharma India Ltd
Completed
Phase 4
Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideDiabetesNCT02610088Seoul National University Bundang Hospital32
Completed
Not Applicable
Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsType 2 DiabetesNCT03071016AstraZeneca2,000
Recruiting
Phase 1
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney DiseaseChronic Kidney DiseasesKidney DiseasesHeart FailureNCT05719714Northwestern University60
Completed
Not Applicable
The potential effect of Dapagliflozin on diabetic macular edemadiabetic macular edema, diabetesJPRN-UMIN000020331Kyoto Prefectural University of Medicine Department of Endocrinology and Metabolism45